CAS 250159-48-9

Formel: C34H70N2O5Pt

InChl: InChI=1S/2C14H28O2.C6H14N2.H2O.Pt/c2*1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16;7-5-3-1-2-4-6(5)8;;/h2*2-13H2,1H3,(H,15,16);5-6H,1-4,7-8H2;1H2;/q;;;;+2/p-2/t;;5-,6-;;/m..1../s1

InChI Key: LWDBMUAJGMXQAY-GSEQGPDBSA-L

SMILES: CCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCC(=O)[O-].C1CC[C@H]([C@@H](C1)N)N.O.[Pt+2]

Miriplatin hydrate

CAS: 250159-48-9

Miriplatin hydrate

Formel: C₃₄H₇₀N₂O₅Pt

Reinheit: ≥98%

Molekulargewicht: 782.01

Ref: 54-BUP05714

Miriplatin hydrate

CAS: 250159-48-9

Formel: C₃₄H₇₀N₂O₅Pt

Reinheit: 98%

Molekulargewicht: 782.008

Ref: IN-DA00BF45

Miriplatin hydrate

CAS: 250159-48-9

Miriplatin hydrate (SM-11355 (hydrate)) (MPT) is a novel platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).

Formel: C₃₄H₇₀N₂O₅Pt

Reinheit: 99.6%

Farbe und Form: White Solid

Molekulargewicht: 782.01

Ref: TM-T21297